Skip to content

Pill Connect

Catch non-adherence while there's still time to fix it.

Pill Connect spots when a participant's dosing slips and alerts your site team while they can still act. You get a clear record of what happened and what was done about it.

Pill Connect Dispenser

How it works

A feedback loop that runs in the background.

Pill Connect closes the loop between a patient deviating from the protocol and a site team knowing, without adding a task to anyone's day.

  1. The patient

    Patients just take their medicine.

    Each pill is dispensed with a button press. This makes data capture and recording automatic and means the time-stamp represents the live event of the patient dispensing and is confirmed by sensors watching the pill eject.

    Explore the dispenser →
  2. The data

    The data moves on its own.

    It leaves the bottle automatically so there's nothing for the patient to open or manually sync with. Remote, continuous per-pill, real-time data on exactly how patients are dispensing, without asking them to do anything beyond dispense the pill.

  3. The site team

    Your site team just supports patients.

    When dosing slips, an email reaches the team that needs this information, with exactly what happened and when. No dashboards to police, just an alert to reach out when it matters.

    See real-time monitoring →

The resultProblems caught while there's still time to act, and a clear record of every one we found and what was done about it.

Adherence you can't see is risk you can't price.

If adherence isn't caught as it happens, you find out at database lock, when a working drug can look like a failure. By then the cost is fixed: the participant is non-evaluable and the endpoint is compromised, with no second study to fall back on in the single-pivotal-trial era.

Why real-time matters →

However the trial plays out, you have a record.

If we never alert you, it's because your participants stayed on track, and you have a documented record that adherence held. Most trials cannot show that at all.

If we do alert you, you get a record of every problem we surfaced, the action your site took, and the dosing that followed. Set that against what a single non-evaluable participant costs to replace in your therapeutic area, and the return is clear. Without it, neither outcome leaves you anything to show.

Pill Connect dispenser beside a lamp on a patient's bedside table
For the participant, it's just their medicine on the bedside table.

Watch

Digital drug accountability.

See how Pill Connect turns every dispense into an objective, auditable record.

Digital drug accountability

Behind the product

Our Team

James Burnstone PhD

James Burnstone PhD

CEO

Joined Elucid mHealth in 2014 as CTO. Moved to CEO and rebranded to Pill Connect in 2017. Lead the original technical design of the companies connected devices. Co-inventor on several patents and now leads customer and partner relationships and clinical trials. Previously completed PhD in Machine Learning and Pattern Recognition.

Robert Smith

Robert Smith

CTO

Leads technical development and quality. Named inventor on several patents. Twelve years in regulated connected products. Previously Lead Systems Engineer at GE Healthcare, following its acquisition of Monica Healthcare.

H

Chris Hall

Chairman

Highly experienced Pharma device expert and company Chairman and NED. Experience includes Aptar Pharma, Bespak and MWV. Now works with NanoPharm, LTS, Merxin and Becton Dickinson.

M

Dr Ian Smith MBE

NED

Founder of Synexus, the global leader in clinical trial recruitment. Then founded Panthera Biopartners, a new recruitment company which he exited again. Led both companies as CMO. NHS GP.

P

Carl Barratt PhD

NED

Founder and CEO of Monica Healthcare, a GE company. Now working as NED and advisor to medical device start ups.

S

Richard Smith

FD

Chartered accountant, previously worked at Astra Zeneca and Advanced Medical Systems.

FAQ

Questions & Answers.

Everything sponsors, CROs and research sites typically ask during evaluation.

Can't find what you're looking for? Contact us →

Clinical Use & Study Design

  1. Is Pill Connect suitable for use in clinical trials and launched drug programs?

    Yes. Pill Connect is suitable for use in clinical trials as well as launched drug programs where objective medication adherence data is required for patients or participants dosing at home.

  2. Is Pill Connect suitable for decentralized or hybrid clinical trials?

    Yes. Pill Connect supports decentralized and hybrid clinical trials by enabling medication adherence data to be collected remotely, without requiring participants to attend site visits solely for adherence monitoring.

  3. How does Pill Connect compare to pill counts or patient diaries?

    Pill Connect provides objective, time-stamped dispensing data, reducing reliance on indirect adherence measures such as pill counts or self-reported patient diaries, which can be incomplete or inaccurate.

  4. What adherence data does Pill Connect collect in a clinical trial?

    Pill Connect records dispensing events, including the date and time each individual pill is dispensed, as well as bottle swap events. This data can be used to support medication adherence analysis during a clinical trial.

Discuss your trial.

Interested in using the Pill Connect Smart Dispenser in your trial — or want to learn more about how it can be used? Get in touch.

Video player